COVID-19 Therapeutics for Nonhospitalized Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 Therapeutics for Nonhospitalized Patients

Published:2022-02-15 Issue:7 Volume:327 Page:617
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Gandhi Rajesh T.¹,Malani Preeti N.²³,del Rio Carlos⁴

Affiliation:

1. Massachusetts General Hospital, Harvard Medical School, Boston

2. Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor

3. Associate Editor, JAMA

4. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Georgia Grady Health System, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2788254/jama_gandhi_2022_vp_220009_1644783368.51948.pdf

Reference10 articles.

1. Mild or moderate Covid-19.;Gandhi;N Engl J Med,2020

2. Early treatment for COVID-19 with SARS-CoV-2 neutralizing antibody sotrovimab.;Gupta;N Engl J Med,2021

3. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.;Owen;Science,2021

4. Early remdesivir to prevent progression to severe COVID-19 in outpatients.;Gottlieb;N Engl J Med

5. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients.;Jayk Bernal;N Engl J Med

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study;Infectious Diseases Now;2024-09

2. COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospital;Journal of Chemotherapy;2024-08-19

3. Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry;Drug Safety;2024-05-09

4. Alpha‐1 adrenergic antagonists and the risk of hospitalization or death in non‐hospitalized patients with COVID‐19: A population‐based study;Fundamental & Clinical Pharmacology;2024-04-04

5. COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina;Journal of Antimicrobial Chemotherapy;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3